T-cell and Retrovirus Studies
T-cell and Retrovirus Studies is a research topic within Immunology. Science Explorer counts 24k research works in it since 1950. 12.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, pathogenesis, clinical manifestations, treatment, and prevention of Human T-cell Leukemia Virus Type 1 (HTLV-1) infection. It covers topics such as viral transmission, proviral load, cellular transformation, immunotherapy, and the role of viral oncogenes in leukemia and lymphoma development.
- HTLV-1
- infection
- leukemia
- lymphoma
- viral transmission
- proviral load
- cellular transformation
- epidemiology
- immunotherapy
- viral oncogenes
- Research works
- 24k fractional, since 1950
- In the world top 10%
- 3.1k per year above
- Top-10% rate
- 12.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -8% the tick is no change
Which countries lead T-cell and Retrovirus Studies research?
By volume, the United States and Brazil publish the most (429 and 410 works in 2022–2025).
By volume, 2022–2025
- 1 United States 429 works
- 2 Brazil 410 works
- 3 Japan 255 works
- 4 China 221 works
- 5 France 79 works
- 6 India 74 works
- 7 Iran 69 works
- 8 United Kingdom 62 works
- 9 Germany 51 works
- 10 Italy 47 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead T-cell and Retrovirus Studies research?
By volume in 2022–2025, The University of Tokyo publishes the most T-cell and Retrovirus Studies research, followed by Universidade de São Paulo and Universidade Federal do Pará.
By volume, 2022–2025
- 1 The University of TokyoJapan 16 works
- 2 Universidade de São PauloBrazil 15 works
- 3 Universidade Federal do ParáBrazil 15 works
- 4 Mashhad University of Medical SciencesIran 13 works
- 5 Kagoshima UniversityJapan 12 works
- 6 The University of Texas MD Anderson Cancer CenterUnited States 11 works
- 7 Fundação Oswaldo CruzBrazil 11 works
- 8 Universidade Estadual de Campinas (UNICAMP)Brazil 9 works
- 9 Kumamoto UniversityJapan 9 works
- 10 Universidade Federal da BahiaBrazil 9 works
Who are the leading researchers in T-cell and Retrovirus Studies?
The most-cited researchers publishing on T-cell and Retrovirus Studies include Hagop M. Kantarjian, Elı́as Campo and David Baltimore.
- 1 Hagop M. Kantarjian United States 4k citations
- 2 Elı́as Campo Spain 3k citations
- 3 David Baltimore United States 2.7k citations
- 4 Carlo M. Croce United States 2.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is T-cell and Retrovirus Studies research done?
The largest centres of T-cell and Retrovirus Studies research in 2022–2025 are São Paulo (Brazil), Tokyo (Japan), Rio de Janeiro (Brazil) and Beijing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Belém and Salvador.
Largest cities, 2022–2025
Where it is the local speciality
- BelémBR · 29.9 works18×
- SalvadorBR · 22.4 works14×
Location quotient: how much more of its research is in T-cell and Retrovirus Studies than the world average.
Where is the best place to study T-cell and Retrovirus Studies?
Among universities, judged by research, Universidade Federal do Pará, Kumamoto University and Mashhad University of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Universidade Federal do ParáBrazil | 55.0 | 0.7% | 16.9× | 15 | +135.3% |
| 2 | Kumamoto UniversityJapan | 54.1 | 17.3% | 31.1× | 9 | +19.1% |
| 3 | Mashhad University of Medical SciencesIran | 47.1 | 1.5% | 26.1× | 13 | +29.3% |
| 4 | Kagoshima UniversityJapan | 44.5 | 4.0% | 56.2× | 12 | -23.9% |
| 5 | The University of TokyoJapan | 38.6 | 4.5% | 6.2× | 16 | -22.4% |
| 6 | Universidade Federal da BahiaBrazil | 31.6 | 3.6% | 13.4× | 9 | -59.0% |
| 7 | University of MiyazakiJapan | 30.4 | 1.2% | 42.6× | 8 | +15.2% |
| 8 | Universidade de São PauloBrazil | 27.9 | 3.3% | 4.1× | 16 | -16.9% |
| 9 | Universidade Estadual de Campinas (UNICAMP)Brazil | 25.0 | 0.2% | 5.4× | 9 | +270.5% |
| 10 | Imperial College LondonUnited Kingdom | 23.5 | 8.0% | 4.3× | 8 | -7.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is T-cell and Retrovirus Studies research growing?
Output in 2018–2022 was 8% lower than in 2013–2017, peaking in 2015. The fastest-growing topics are T-cell and Retrovirus Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.